Terms: = Lung cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Prognosis
3 results:
1. Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma.
Liu ZT; Shen JT; Lei YJ; Huang YC; Zhao GQ; Zheng CH; Wang X; Wang YT; Chen L; Li ZX; Li SZ; Liao J; Yu TD
BMC Cancer; 2023 Nov; 23(1):1141. PubMed ID: 38001428
[TBL] [Abstract] [Full Text] [Related]
2. Impact of palliative radiotherapy with or without lung irradiation in patients with interstitial lung disease.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Sugawara Y; Kozuki T
Radiother Oncol; 2023 Jun; 183():109636. PubMed ID: 36963439
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base.
Jiao XD; Qin BD; You P; Cai J; Zang YS
Lung Cancer; 2018 Sep; 123():70-75. PubMed ID: 30089598
[TBL] [Abstract] [Full Text] [Related]
